Literature DB >> 15968969

Ethical issues in the economic assessment of health care technologies.

J Moatti1.   

Abstract

This paper challenges traditional views which oppose health economics and medical ethics by arguing that economic assessment is a necessary complement to medical ethics and can help to improve public participation and democratic processes in choices about resource allocation for health care technologies. In support of this argument, four points are emphasized: (1) Most current biomedical ethical debates implicitly deal with economic issues of resource allocation. (2) Clinical decisions, which usually respect the Hippocratic code of ethics, are nevertheless influenced by economic incentives and constraints. (3) Economic assessment is concerned with both efficiency and equity and potential trade-offs between the two, which means that ethical judgements are always embedded in welfare economics. (4) The real debate is not between economics on the one side and medical ethics on the other. Rather it is between different ethical conceptions of social justice and the contrasting approaches they entail to reconciling individual interests and preferences with collective goods and welfare.

Entities:  

Keywords:  Analytical Approach; Health Care and Public Health

Mesh:

Year:  1999        PMID: 15968969     DOI: 10.1023/a:1009437104347

Source DB:  PubMed          Journal:  Health Care Anal        ISSN: 1065-3058


  11 in total

1.  The gene: harnessing the gene and remaking the world, by Jeremy Rifkin.

Authors:  Neil A Holtzman
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

2.  Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

Authors:  I S Udvarhelyi; G A Colditz; A Rai; A M Epstein
Journal:  Ann Intern Med       Date:  1992-02-01       Impact factor: 25.391

Review 3.  Utilisation as a measure of equity: weighing heat?

Authors:  G Mooney; J Hall; C Donaldson; K Gerard
Journal:  J Health Econ       Date:  1991       Impact factor: 3.883

4.  [Should hepatitis C be screened? Socioeconomic analysis of different screening strategies for chronic hepatitis C in French population].

Authors:  M Rotily; S Loubière; J Nixon; M Bourlière; P Halfon; J P Moatti
Journal:  Gastroenterol Clin Biol       Date:  1997

5.  Discrepancy between medical decisions for individual patients and for groups.

Authors:  D A Redelmeier; A Tversky
Journal:  N Engl J Med       Date:  1990-04-19       Impact factor: 91.245

6.  Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial.

Authors:  O Hartmann; A G Le Corroller; D Blaise; J Michon; I Philip; F Norol; M Janvier; J L Pico; M C Baranzelli; H Rubie; C Coze; A Pinna; V Méresse; E Benhamou
Journal:  Ann Intern Med       Date:  1997-04-15       Impact factor: 25.391

7.  Just caring: Oregon, health care rationing, and informed democratic deliberation.

Authors:  L M Fleck
Journal:  J Med Philos       Date:  1994-08

8.  Comparison of anxiety, pain and discomfort in two procedures of hematopoietic stem cell collection: leukacytapheresis and bone marrow harvest.

Authors:  P Auquier; G Macquart-Moulin; J P Moatti; J L Blache; G Novakovitch; D Blaise; C Faucher; P Viens; D Maraninchi
Journal:  Bone Marrow Transplant       Date:  1995-10       Impact factor: 5.483

9.  Assessing the cost effectiveness of adjuvant therapies in early breast cancer using a decision analysis model.

Authors:  B E Hillner; T J Smith; C E Desch
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care.

Authors:  G Macquart-Moulin; P Viens; M L Bouscary; D Genre; M Resbeut; G Gravis; J Camerlo; D Maraninchi; J P Moatti
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  1 in total

1.  An economic analysis of chromosome testing in couples with children who have structural chromosome abnormalities.

Authors:  Kittiphong Thiboonboon; Wantanee Kulpeng; Yot Teerawattananon
Journal:  PLoS One       Date:  2018-06-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.